Latest articles
New global survey shows public perceptions of lung cancer
New global survey shows public perceptions of lung cancer and also highlights that people believe that prognoses for the disease are dire, and there...
Novartis highlights progress in R&D pipeline
Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
MSD’s new HIV-1 treatment approved for use on the NHS
MSD's new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine...
Popular articles
MSD’s new HIV-1 treatment approved for use on the NHS
MSD's new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine...
Novartis highlights progress in R&D pipeline
Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Pharma in 2019: Has uncertainty led to pharma innovation and change?
As the year draws to a close, has uncertainty led to pharma innovation and change in 2019? Have we been in a Brexit-related stasis?...
Pharmaceutical direct-to-consumer advertising in Europe
DTCA provides a favourable environment for shared decision-making wherein the patient is aware of the risks and benefits of new drugs. It also addresses...